Magnetic Hearing Device Avoids Skin Penetration
|
By HospiMedica International staff writers Posted on 02 Jan 2014 |

Image: The Baha 4 Attract system (Photo courtesy of Cochlear).
A novel cochlear hearing device creates a pathway for bone conduction hearing, without the need for an abutment that pierces the skin.
The Baha 4 Attract system consists of a titanium implant placed in the mastoid process behind the ear, which allows for transmission of sound vibrations to the inner ear. An advanced sound processor, which uses a front microphone to pick up sounds facing the user and a secondary microphone to filter surrounding noise, sends vibrations to an external magnet, which are transmitted to the internal magnet, which rests under the skin. The internal magnet then relays the vibrations to the titanium implant that is placed in the bone, which in turn transmits the sound waves to the inner ear.
The sound processor uses the Ardium platform, which is three times faster and has eight times more memory than previous generation processors. The added computing power is used to drive sophisticated sound technologies, together with true 2.4 GHz digital wireless connectivity and remote controls. The Baha 4 Attract system is a product of Cochlear (Centennial, CO, USA), and has been approved by the US Food and Drug Administration (FDA).
“The Baha 4 Attract System sets new standards in simplicity, comfort, and hearing performance for magnetic bone conduction implant systems,” said Chris Smith, president of Cochlear. “We are pleased to be bringing this new hearing option to patients who want to enjoy the benefits of the Baha System without a skin penetrating abutment. Cochlear is dedicated to being a leader in bone conduction and this important milestone further emphasizes our commitment to continuing our legacy in innovation.”
In a normal ear, sound vibrations in the air lead to resonant vibrations of the basilar membrane inside the cochlea. The movement of hair cells, located all along the basilar membrane, creates an electrical disturbance that can be picked up by the surrounding nerve cells. The brain is able to interpret the nerve activity to determine which area of the basilar membrane is resonating, and therefore what sound frequency is being heard. The cochlear implant bypasses the hair cells and stimulates the cochlear nerves directly using electrical impulses. This allows the brain to interpret the frequency of sound as it would if the hair cells of the basilar membrane were functioning properly.
Related Links:
Cochlear
The Baha 4 Attract system consists of a titanium implant placed in the mastoid process behind the ear, which allows for transmission of sound vibrations to the inner ear. An advanced sound processor, which uses a front microphone to pick up sounds facing the user and a secondary microphone to filter surrounding noise, sends vibrations to an external magnet, which are transmitted to the internal magnet, which rests under the skin. The internal magnet then relays the vibrations to the titanium implant that is placed in the bone, which in turn transmits the sound waves to the inner ear.
The sound processor uses the Ardium platform, which is three times faster and has eight times more memory than previous generation processors. The added computing power is used to drive sophisticated sound technologies, together with true 2.4 GHz digital wireless connectivity and remote controls. The Baha 4 Attract system is a product of Cochlear (Centennial, CO, USA), and has been approved by the US Food and Drug Administration (FDA).
“The Baha 4 Attract System sets new standards in simplicity, comfort, and hearing performance for magnetic bone conduction implant systems,” said Chris Smith, president of Cochlear. “We are pleased to be bringing this new hearing option to patients who want to enjoy the benefits of the Baha System without a skin penetrating abutment. Cochlear is dedicated to being a leader in bone conduction and this important milestone further emphasizes our commitment to continuing our legacy in innovation.”
In a normal ear, sound vibrations in the air lead to resonant vibrations of the basilar membrane inside the cochlea. The movement of hair cells, located all along the basilar membrane, creates an electrical disturbance that can be picked up by the surrounding nerve cells. The brain is able to interpret the nerve activity to determine which area of the basilar membrane is resonating, and therefore what sound frequency is being heard. The cochlear implant bypasses the hair cells and stimulates the cochlear nerves directly using electrical impulses. This allows the brain to interpret the frequency of sound as it would if the hair cells of the basilar membrane were functioning properly.
Related Links:
Cochlear
Latest Surgical Techniques News
- Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
- Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read more
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







